Homocystinuria: a rare cause of megaloblastic anemia

Sunil Gomber1, Pooja Dewan, Tarun Dua

  • 1Department of Pediatrics, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India. sunilgomber@hotmail.com

Indian Pediatrics
|October 12, 2004
PubMed

Insights

Homocystinuria, a metabolic disorder, can cause megaloblastic anemia in children. Prompt diagnosis and treatment with pyridoxine and folic acid can improve anemia symptoms.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Genetics

Background:

  • Megaloblastic anemia is a common hematological disorder in children.
  • Homocystinuria is a rare inherited metabolic disorder affecting amino acid metabolism.

Observation:

  • An eight-year-old boy presented with megaloblastic anemia and later developed lens dislocation.
  • The patient exhibited a positive sodium nitroprusside test, indicating elevated urinary homocysteine levels.

Findings:

  • The child was diagnosed with homocystinuria type 1.
  • Anemia resolved with pyridoxine and folic acid supplementation.

Implications:

  • Homocystinuria should be considered in the differential diagnosis of pediatric megaloblastic anemia.
  • Early detection and management of homocystinuria can prevent severe complications like lens dislocation.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...